PFMU
KRON

Privium Fund Management (UK)’s Kronos Bio KRON Stock Holding History

Privium Fund Management (UK)’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-292,182
Closed -$342K – 87
2024
Q2 		$342K Hold
292,182
– – 0.13% 121
2024
Q1 		$403K Hold
292,182
– – 0.2% 68
2023
Q4 		$365K Hold
292,182
– – 0.25% 58
2023
Q3 		$365K Hold
292,182
– – 0.29% 56
2023
Q2 		$485K Hold
292,182
– – 0.38% 53
2023
Q1 		$456K Sell
292,182
-77,220
-21% -$148K 0.36% 48
2022
Q4 		$598K Sell
369,402
-275,929
-43% -$635K 0.45% 35
2022
Q3 		$2.16M Buy
645,331
+214,982
+50% +$970K 2.76% 11
2022
Q2 		$1.57M Buy
+430,349
New +$1.95M 1.77% 16

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Privium Fund Management (UK)'s KRON Position: Q3 2024 in Review

Privium Fund Management (UK) sold out of Kronos Bio (KRON) in Q3 2024, closing a stake of 292,182 shares — an estimated $342K sold.

Privium Fund Management (UK) first reported a position in KRON in Q2 2022 and held it in 9 quarters. The position peaked at $2.16M in Q3 2022. 53 funds tracked by Wall St. Rank hold KRON as of Q3 2024.

  • Privium Fund Management (UK) reported no remaining Kronos Bio position as of Q3 2024 after selling out during the quarter.
  • Privium Fund Management (UK) sold 292,182 Kronos Bio shares in Q3 2024, an estimated $342K.
  • Privium Fund Management (UK) first reported a position in Kronos Bio in Q2 2022 and held it in 9 quarters.
  • Privium Fund Management (UK)'s Kronos Bio position peaked at $2.16M in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2024, filed 5 Nov 2024.